Insider · CIK 0001654363

Ambrogi Michael J.

Reports to the SEC for 1 company · MALVERN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001654363

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-07-22	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+8,426 sh	$11.46	+$96.6K	229,293
2020-07-22	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−400 sh	$65.53	−$26.2K	228,893
2020-07-22	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−4,228 sh	$66.77	−$282K	224,665
2020-07-22	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−3,798 sh	$67.48	−$256K	220,867
2020-07-22	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+3,774 sh	$11.46	+$43.3K	224,641
2020-07-22	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−1,151 sh	$66.50	−$76.5K	223,490
2020-07-22	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−2,623 sh	$67.28	−$176K	220,867
2020-07-22	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+30.8K sh	$21.15	+$651K	251,639
2020-07-22	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−1,380 sh	$65.49	−$90.4K	250,259
2020-07-22	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−12.2K sh	$66.66	−$814K	238,042
2020-07-22	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−17.2K sh	$67.39	−$1.16M	220,867
2020-07-22	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,426 sh	—	—	0
2020-07-22	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,774 sh	—	—	0
2020-07-22	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−30.8K sh	—	—	67,586
2020-07-21	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+300 sh	$11.46	+$3,438	221,167
2020-07-21	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−300 sh	$65.07	−$19.5K	220,867
2020-07-21	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+3,021 sh	$21.15	+$63.9K	223,888
2020-07-21	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−3,021 sh	$65.06	−$197K	220,867
2020-07-21	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−300 sh	—	—	8,426
2020-07-21	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,021 sh	—	—	98,358
2020-04-14	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+35.7K sh	$7.15	+$256K	256,612
2020-04-14	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−27.1K sh	$70.99	−$1.93M	221,244
2020-04-14	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−377 sh	$71.75	−$27.1K	220,867
2020-04-14	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−35.7K sh	—	—	44,514
2020-04-13	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+22.8K sh	$7.15	+$163K	243,622
2020-04-13	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−22.8K sh	$69.01	−$1.57M	220,867
2020-04-13	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−8,226 sh	$70.18	−$577K	248,386
2020-04-13	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−22.8K sh	—	—	80,259
2020-03-06	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−2,274 sh	$69.53	−$158K	220,867
2020-03-03	NVCRNovoCure LtdA Award	Chief Operating Officer	AAward	+14.4K sh	—	—	223,141
2020-03-03	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Chief Operating Officer	AAward	+27.8K sh	—	—	27,794
2020-02-28	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−2,673 sh	$72.22	−$193K	208,726
2020-02-27	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,173 sh	$79.45	+$490K	211,399
2020-02-27	NVCRNovoCure Ltd · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,173 sh	—	—	6,172
2020-02-25	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−11.6K sh	$81.16	−$945K	205,226
2020-02-24	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+31.2K sh	$88.26	+$2.75M	216,873
2020-02-24	NVCRNovoCure Ltd · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−31.2K sh	—	—	0
2019-11-04	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10.1K sh	$14.37	+$145K	195,743
2019-11-04	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−10.1K sh	$79.00	−$795K	185,674
2019-11-04	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+37K sh	$22.00	+$813K	222,631
2019-11-04	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−37K sh	$79.00	−$2.92M	185,674
2019-11-04	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+33.8K sh	$21.15	+$715K	219,467
2019-11-04	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−33.8K sh	$79.00	−$2.67M	185,674
2019-11-04	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10.1K sh	—	—	0
2019-11-04	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−37K sh	—	—	0
2019-11-04	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−33.8K sh	—	—	96,651
2019-06-19	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+111K sh	$22.00	+$2.44M	296,542
2019-06-19	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−111K sh	$60.00	−$6.65M	185,674
2019-06-19	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−111K sh	—	—	36,957
2019-06-06	NVCRNovoCure LtdM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,999 sh	$7.15	+$42.9K	191,673

Recent filings

Accepted (ET)
Jul 234
Ambrogi Michael J.0001645113-20-000101
SEC(opens sec.gov)

Companies

NovoCure LtdChief Operating OfficerNVCR

Address

C/O NOVOCURE INC., 20 VALLEY STREAM PKWY SUITE 300

MALVERN, PA, 19355